12:00 AM
 | 
Nov 12, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Augment Injectable Bone Graft regulatory update

BioMimetic disclosed in its 3Q12 earnings that it submitted a Device License Application (DLA) to Health Canada for Augment Injectable Bone Graft. In June, BioMimetic reported data from a Canadian pivotal trial...

Read the full 137 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >